IMS Health (RX) Acquired for $22/Share by TPG and CPP Investment Board
More News related to RX
- Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low
- IMS Health to Launch Oncology Quantifier, Delivering Integrated Insights for Enhanced Market Measurement, Commercial Strategies
- Law Offices of Brian M. Felgoise, P.C. Announces Investigation on Behalf of Shareholders of IMS Health, Inc.
- Top 10 News Items 11/02-11/06: Unemployment Rate Now Over 10%, Fed to Keep Rates 'Exceptionally Low' for 'Extended Period', Buffett Does the Biggest Deal of His Life
- Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of IMS Health, Inc.
IMS Health (NYSE: RX) entered into a definitive agreement to be acquired by investment funds managed by TPG Capital and the CPP Investment Board in a transaction with a total value of $5.2 billion, including the assumption of debt.
Under the agreement, IMS shareholders will receive $22.00 cash for each share of IMS common stock they own, representing a premium of approximately 50 percent over the closing share price on Friday, October 16, 2009, the last trading day prior to public speculation that IMS was considering its strategic alternatives.
Shares of RX closed at $16.81 yesterday.
Related Categories
Hot ListMergers and Acquisitions
Rumors
Stocks Mentioned
+0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
